Current Status of Imaging Infections with Radiolabeled Anti-Infective Agents

M. Welling, G. Ferro-Flores, I. Pirmettis, C. Brouwer
{"title":"Current Status of Imaging Infections with Radiolabeled Anti-Infective Agents","authors":"M. Welling, G. Ferro-Flores, I. Pirmettis, C. Brouwer","doi":"10.2174/187152109788680180","DOIUrl":null,"url":null,"abstract":"Infection specific radiopharmaceuticals can be used for diagnosis, decision-making in therapy and treatment follow-up. Research has been ongoing to develop infection specific markers since clinically used tracers cannot discriminate between infection and inflammation. A specific radiopharmaceutical for infection imaging should satisfy the following criteria: high and specific uptake at the infection site, rapid infection detection and background clearance, minimal accumulation in non-target tissues, low toxicity, zero immune response and especially the ability to differentiate infection from sterile inflammation. Radiolabeled anti-infective agents can fulfill the majority of these requirements. Technetium-99m (99mTc) labeled antibiotics have potential to differentiate sterile inflammation from infection. There are numerous studies reporting the use of radiolabeled antibacterial and antifungal agents for infection detection. Other promising agents are antimicrobial peptides (AMPs) since they preferentially bind to bacteria membranes instead of those of mammalian cells thus distinguishing between infection and sterile inflammation. Synthetic AMPs derived from human natural peptides offers possibility for studying the effects of polymerization and substituting the amino acid sequence to design a specific micro-organism seeking tracer. 99mTc-labeled anti-infectives are ideal as infection-seeking agents because of its direct and fast accumulation. Clinical studies already undertaken and further evaluation with different pathogen types such as viruses, fungi, parasites and intracellular pathogens in humans will improve the potential of these compounds. Radiochemical techniques for labeling anti-infectives have been developed to optimize biodistribution and targeting properties of tracers. An important issue is the technetium-99m specific coordination site in the anti-infective molecule and its chemical and biochemical characterization. © 2009 Bentham Science Publishers Ltd.","PeriodicalId":89320,"journal":{"name":"Anti-infective agents in medicinal chemistry","volume":"8 1","pages":"272-287"},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anti-infective agents in medicinal chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/187152109788680180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

Infection specific radiopharmaceuticals can be used for diagnosis, decision-making in therapy and treatment follow-up. Research has been ongoing to develop infection specific markers since clinically used tracers cannot discriminate between infection and inflammation. A specific radiopharmaceutical for infection imaging should satisfy the following criteria: high and specific uptake at the infection site, rapid infection detection and background clearance, minimal accumulation in non-target tissues, low toxicity, zero immune response and especially the ability to differentiate infection from sterile inflammation. Radiolabeled anti-infective agents can fulfill the majority of these requirements. Technetium-99m (99mTc) labeled antibiotics have potential to differentiate sterile inflammation from infection. There are numerous studies reporting the use of radiolabeled antibacterial and antifungal agents for infection detection. Other promising agents are antimicrobial peptides (AMPs) since they preferentially bind to bacteria membranes instead of those of mammalian cells thus distinguishing between infection and sterile inflammation. Synthetic AMPs derived from human natural peptides offers possibility for studying the effects of polymerization and substituting the amino acid sequence to design a specific micro-organism seeking tracer. 99mTc-labeled anti-infectives are ideal as infection-seeking agents because of its direct and fast accumulation. Clinical studies already undertaken and further evaluation with different pathogen types such as viruses, fungi, parasites and intracellular pathogens in humans will improve the potential of these compounds. Radiochemical techniques for labeling anti-infectives have been developed to optimize biodistribution and targeting properties of tracers. An important issue is the technetium-99m specific coordination site in the anti-infective molecule and its chemical and biochemical characterization. © 2009 Bentham Science Publishers Ltd.
放射性标记抗感染药物成像感染的现状
感染特异性放射性药物可用于诊断、治疗决策和治疗随访。由于临床使用的示踪剂无法区分感染和炎症,因此开发感染特异性标志物的研究一直在进行中。用于感染成像的特异性放射性药物应满足以下标准:感染部位的高特异性摄取,快速的感染检测和背景清除,在非靶组织中的最小积累,低毒性,零免疫反应,特别是能够区分感染和无菌炎症。放射性标记的抗感染药物可以满足大多数这些要求。锝-99m (99mTc)标记的抗生素有可能区分无菌炎症和感染。有许多研究报告使用放射性标记的抗菌和抗真菌药物进行感染检测。其他有希望的药物是抗菌肽(AMPs),因为它们优先结合细菌膜而不是哺乳动物细胞膜,从而区分感染和无菌炎症。从人类天然多肽中提取的合成AMPs为研究聚合效应和取代氨基酸序列来设计特定的微生物寻求示踪剂提供了可能。99mtc标记的抗感染药物由于其直接和快速的积累而成为理想的寻找感染的药物。已经开展的临床研究以及对人类不同病原体类型(如病毒、真菌、寄生虫和细胞内病原体)的进一步评估将提高这些化合物的潜力。用于标记抗感染药物的放射化学技术已被开发出来,以优化示踪剂的生物分布和靶向性。一个重要的问题是抗感染分子中的锝-99m特异性配位位点及其化学和生化表征。©2009边沁科学出版有限公司
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书